ASSESSMENT OF FRACTURE RISK FOR PATIENTS ON AROMATASE INHIBITORS

被引：0
|
作者：
Cefai, E. C. [1 ]
Balzan, D. B. [1 ]
Attard, R. A. [1 ]
Borg, A. B. [1 ]
Mercieca, C. M. [1 ]
机构：
[1] Mater Dei Hosp, Dept Rheumatol, Msida, Malta
来源：
OSTEOPOROSIS INTERNATIONAL | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P276
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [1] FRACTURE RISK ASSESSMENT OF PATIENTS ON AROMATASE INHIBITORS: IS FRACTURE RISK BEING ADDRESSED APPROPRIATELY FOR PATIENTS TAKING AROMATASE INHIBITORS?
    Cefai, Erika
    Balzan, Daniela
    Attard, Ruth
    Mercieca, Cecilia
    Borg, Andrew
    [J]. RHEUMATOLOGY, 2018, 57
  • [2] ASSESSMENT OF OSTEOPOROSIS RISK IN PATIENTS INTIATING AROMATASE INHIBITORS FOR BREAST CANCER
    Dolan, L.
    Vandenbosch, P.
    Kendall, J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S302 - S303
  • [3] Aromatase Inhibitors and Risk of Myocardial Infarction, Stroke and Fracture
    Ligibel, J. A.
    O'Malley, A.
    Fisher, M.
    Daniel, G.
    Winer, E. P.
    Keating, N. L.
    [J]. CANCER RESEARCH, 2010, 70
  • [4] A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors
    Hook, Christine
    Chatterjee, Udit
    Sheng, Haiyang
    Zhu, Qianqian
    Robinson, Timothy
    Roh, Janise M.
    Laurent, Cecile A.
    Lee, Catherine
    Delmerico, Jennifer
    Lo, Joan C.
    Ambrosone, Christine B.
    Kushi, Lawrence H.
    Kwan, Marilyn L.
    Yao, Song
    [J]. NPJ BREAST CANCER, 2024, 10 (01)
  • [5] A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors
    Christine Hook
    Udit Chatterjee
    Haiyang Sheng
    Qianqian Zhu
    Timothy Robinson
    Janise M. Roh
    Cecile A. Laurent
    Catherine Lee
    Jennifer Delmerico
    Joan C. Lo
    Christine B. Ambrosone
    Lawrence H. Kushi
    Marilyn L. Kwan
    Song Yao
    [J]. npj Breast Cancer, 10
  • [6] Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients
    Berruti, Alfredo
    Tucci, Marcello
    Mosca, Alessandra
    Vana, Federica
    Ardine, Mara
    Dogliotti, Luigi
    Angeli, Alberto
    Bertoldo, Francesco
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) : 1455 - 1456
  • [7] Fracture threshold in breast cancer patients treated with adjuvant aromatase inhibitors
    Bertoldo, F.
    Dalle Carbonare, L.
    Zenari, S.
    Pancheri, S.
    Zanatta, M.
    Giovanazzi, B.
    Valenti, M. T.
    Lo Cascio, V.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S161 - S161
  • [8] Risk factors for incident fracture in patients with breast cancer treated with aromatase inhibitors: B-ABLE cohort
    Garcia-Giralt, N.
    Pineda-Moncusi, M.
    Ovejero, D.
    Aymar, I
    Soldado-Folgado, J.
    Campodarve, I
    Rodriguez-Morera, J.
    Nogues, X.
    [J]. REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2020, 12 (01) : 7 - 13
  • [9] Aromatase inhibitors - a risk for the brain?
    Wenderlein, JM
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2005, 65 (02) : 144 - 148
  • [10] Interaction of fracture risk in an aromatase inhibitor therapy with other fracture risk
    不详
    [J]. OSTEOLOGIE, 2009, 18 (04) : 331 - 331
12345